Literature DB >> 15469193

A polydiagnostic and dimensional comparison of epileptic psychoses and schizophrenia spectrum disorders.

Masato Matsuura1, Naoto Adachi, Yasunori Oana, Yoshiro Okubo, Masaaki Kato, Takashi Nakano, Noriyoshi Takei.   

Abstract

After establishing the validity of the Japanese version of the Operational Criteria Checklist for Psychotic Illness (OPCRIT), we applied it to 58 consecutive patients with epileptic psychoses (index group) and to age- and sex-matched controls with schizophrenia spectrum disorders (control group). Compared with the control group, the index group had a low family history of schizophrenia, high premorbid personality disorder and unemployment, abrupt or acute onset of psychosis, good recovery with single or multiple episodes, and low deterioration from a premorbid level of function. From 9% to 52% of the index group and 38% to 84% of the control group were diagnosed with schizophrenia according to the operational criteria used. The percentages of patients diagnosed with schizophrenia based on various diagnostic criteria in the two groups were similar. In the index group, a diagnosis of schizophrenia was more commonly made among patients with inter-ictal psychosis than among those with post-ictal psychosis. An exploratory factor analysis identified five factor solutions of manic, negative, depressive, vegetative, and positive symptoms. Although positive and negative factor values were lower in the index group than in the control group, the two groups shared a similar factor profile. These results indicate that the difference in symptomatology between the two groups was quantitative rather than qualitative.

Entities:  

Mesh:

Year:  2004        PMID: 15469193     DOI: 10.1016/s0920-9964(02)00492-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

Review 1.  First rank symptoms for schizophrenia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman; Clare Davenport; Amanda J Kirkham; Sarah Grabowski; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

2.  Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

Review 3.  Schizophrenia and epilepsy: is there a shared susceptibility?

Authors:  Nicola G Cascella; David J Schretlen; Akira Sawa
Journal:  Neurosci Res       Date:  2009-04       Impact factor: 3.304

4.  Psychotic illness in patients with epilepsy.

Authors:  Kousuke Kanemoto; Yukari Tadokoro; Tomohiro Oshima
Journal:  Ther Adv Neurol Disord       Date:  2012-11       Impact factor: 6.570

Review 5.  A review of the reliability and validity of OPCRIT in relation to its use for the routine clinical assessment of mental health patients.

Authors:  Philip J Brittain; Daniel Stahl; James Rucker; Jamie Kawadler; Gunter Schumann
Journal:  Int J Methods Psychiatr Res       Date:  2013-05-09       Impact factor: 4.035

6.  Epilepsy, mental health disorder, or both?

Authors:  Vadim Beletsky; Seyed M Mirsattari
Journal:  Epilepsy Res Treat       Date:  2011-12-15

7.  Non-participation may bias the results of a psychiatric survey: an analysis from the survey including magnetic resonance imaging within the Northern Finland 1966 Birth Cohort.

Authors:  Marianne Haapea; Jouko Miettunen; Juha Veijola; Erika Lauronen; Päivikki Tanskanen; Matti Isohanni
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-04-02       Impact factor: 4.519

8.  Harnessing clinical psychiatric data with an electronic assessment tool (OPCRIT+): the utility of symptom dimensions.

Authors:  Philip James Brittain; Sarah Elizabeth Margaret Lobo; James Rucker; Myanthi Amarasinghe; Anantha Padmanabha Pillai Anilkumar; Martin Baggaley; Pallavi Banerjee; Jenny Bearn; Matthew Broadbent; Matthew Butler; Colin Donald Campbell; Anthony James Cleare; Luiz Dratcu; Sophia Frangou; Fiona Gaughran; Matthew Goldin; Annika Henke; Nikola Kern; Abdallah Krayem; Faiza Mufti; Ronan McIvor; Humphrey Needham-Bennett; Stuart Newman; Dele Olajide; David O'Flynn; Ranga Rao; Ijaz Ur Rehman; Gertrude Seneviratne; Daniel Stahl; Sajid Suleman; Janet Treasure; John Tully; David Veale; Robert Stewart; Peter McGuffin; Simon Lovestone; Matthew Hotopf; Gunter Schumann
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

9.  Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis?

Authors:  Judith Allardyce; Robin G McCreadie; Gary Morrison; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-05-14       Impact factor: 4.328

10.  Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife.

Authors:  Irina Rannikko; Graham K Murray; Pauliina Juola; Henri Salo; Marianne Haapea; Jouko Miettunen; Juha Veijola; Jennifer H Barnett; Anja P Husa; Peter B Jones; Marjo-Riitta Järvelin; Matti Isohanni; Erika Jääskeläinen
Journal:  Schizophr Res Cogn       Date:  2015-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.